May 8th 2024
Findings suggest unstable housing may inhibit direct-acting antiviral treatment initiation in PWID with unstable housing compared to those with stable housing.
Seladelpar Improves Markers of Cholestasis, Pruritus in Patients with PBC
November 12th 2023Phase 3 data presented at The Liver Meeting 2023 from the American Association for the Study of Liver Diseases demonstrated the safety and efficacy of seladelpar in patients with primary biliary cholangitis through 12 months of treatment.
Assisted Reproductive Technology Safe, Effective for Patients with Chronic Liver Disease
November 11th 2023Data presented at The Liver Meeting 2023 from the American Association for the Study of Liver Diseases (AASLD) showed similar assisted reproductive technology outcomes for patients with and without chronic liver disease.
Alcohol Use Disorder Diagnosis, Treatment Associated with Decreased Risk of Mortality
October 23rd 2023Presented at ACG 2023, findings from a retrospective cohort analysis revealed patients with ALD diagnosed with and prescribed at least 1 medication for alcohol use disorder had a decreased risk of mortality.
The Rise of Obesity in the US: Recognizing Gastrointestinal and Hepatic Comorbidities
October 6th 2023Obesity rates in the US have skyrocketed, and so has the prevalence of several comorbid gastrointestinal and hepatic diseases - not all patients know their risks or have the financial means to take preventative measures.